MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option
2010 Buccisano, F; Maurillo, L; Del Principe, M I; Cerretti, R; Consalvo M, A Irno; Fraboni, D; Panetta, P; Campagna, S; Ottaviani, L; Sarlo, C; De Angelis, G; Ditto, C; Di Caprio, L; Cefalo, M G; Ammatuna, E; Duranti, F; Lo Coco, F; Arcese, W; Amadori, S; Venditti, A
Zoster-related pain in haematological malignancies: Prompt and stable relief of refractory pain syndromes by oxycodone
2007 Niscola, F; Cartoni, C; Piccioni, D; Del Poeta, G; Scaramucci, L; Romani, C; Maurillo, L; Palombi, M; Brunetti, G A; D'Elia, G M; Giovannini, M; Perrotti, A P; De Fabritiis, P
Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)
2014 Del Poeta, G; Del Principe, Mi; Dal Bo, M; Buccisano, F; Ragusa, D; Pozzo, F; Bulian, P; Maurillo, L; Rossi, D; Venditti, A; De Fabritiis, P; Gaidano, G; Amadori, S; Gattei, V
Monitoring of minimal residual disease in acute myeloid leukemia using peripheral blood as an alternative source to bone marrow
2007 Maurillo, L; Buccisano, F; Del Poeta, G; Spagnoli, A; Neri, B; Del Principe, M I; Cupelli, L; Luciano, F; De Fabritiis, P; Amadori, S; Venditti, A
Rituximab Maintenance Following Chemoimmunotherapy Improves Outcome in B-Cell Chronic Lymphocytic Leukemia
2009 Del Poeta, G; Del Principe, M I; Ragusa, D; Maurillo, L; Buccisano, F; Ottaviani, L; Gianni, L; Luciano, F; Bulian, P; Rossi, F M; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S
The amount of spontaneous apoptosis predicts outcome in acute myeloid leukemia (AML)
2000 Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Del Moro, B; Suppo, G; Epiceno, Am; Cox, Mc; Masi, M; Amadori, S
Umbilical cord blood banking: Variability in leukocyte count and differential by two automated hematology analysers
1999 Bruno, A; Ragusa, D; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Caravita, T; Zinno, F; Lanti, A; Santinelli, S; Buccisano, F; Tamburini, A; Maurillo, L; Picardi, A; Isacchi, G; Amadori, S
Idiopathic hypereosinophilic syndrome (HES) with FIP1L1-PDGFRA rearrangement can be effectively treated with Imatinib
2004 Martinelli, G; Cilloni, D; Ottaviani, E; Malagola, M; Messa, F; Rondoni, M; Bosi, C; Gottardi, E; Rosti, G; Ricci, P; Gaitani, S; Pane, F; Testoni, N; Mecucci, C; Soverini, S; Piccaluga, Pp; Amabile, M; Tiribelli, M; Zaccaria, A; Grafone, T; De Vivo, A; Pileri, S; Fattori, P; Bocchia, M; Serra, A; Maurillo, L; Fanin, R; Cross, Ncp; Merante, S; Cazzola, M; Alimena, G; Frassoni, F; Galieni, P; Russo, D; Gobbi, M; Gugliotta, L; Lauria, F; Mazza, P; Ferrara, F; Gherlinzoni, F; Leoni, P; Musto, P; Baccarani, M; Saglio, G
Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia
2006 Buccisano, F; Maurillo, L; Gattei, V; Del Poeta, G; Del Principe, M I; Fraboni, D; Panetta, P; Consalvo, M Irno; Campagna, S; Gianni, L; Ottaviani, L; Postorino, M; De Fabritiis, P; Arcese, W; Lo Coco, F; Amadori, S; Venditti, A
Bcl-2 overexpression identifies a subset of patients with acute myeloid leukemia at worse prognosis within the intermediate/favorable cytogenetic risk group
1998 Del Poeta, G; Venditti, A; Aronica, G; Buccisano, F; Cox, Mc; Maurillo, L; Tamburini, A; Bruno, A; Masi, M; Amadori, S
Hodgkin lymphoma in mutated ZAP-70 negative B-CELL chronic lymphocytic leukemia: A case report
2007 Niscola, P; Del Principe, M I; Palombi, M; Fratoni, S; Piccioni, D; Maurillo, L; De Fabritiis, P; Amadori, S; Del Poeta, G
Minimal residual disease is detectable in peripheral blood of patients with acute myeloid leukemia and provides prognostic information
2007 Maurillo, L; Buccisano, F; Del Poeta, G; Spagnoli, A; Neri, B; Del Principe, M I; Ammatuna, E; Tendas, A; Luciano, F; De Fabritiis, P; Amadori, S; Vendetti, A
P-glycoprotein (PGP) and CD71 overexpression combined with low bcl-2 identify patients at worse prognosis in acute lymphoid leukemia (ALL)
1999 Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Cox, Mc; Epiceno, Am; Del Moro, B; Battaglia, A; Del Principe, Mi; Bruno, A; Masi, M; Amadori, S
Clinical relevance of bcl-2 expression in de novo acute myeloid leukemia (AML)
1999 Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Cox, Mc; Epiceno, Am; Del Moro, B; Battaglia, A; Del Principe, Mid; Bruno, A; Masi, M; Amadori, S
Risk-adapted transplant selection improves outcome of adult patients with high-risk AML
2012 Buccisano, F; Maurillo, L; Del Principe, M I; Cerretti, R; Sarlo, C; Picardi, A; Cefalo, M; Ottaviani, L; De Angelis, G; Ditto, C; Di Veroli, A; Consalvo, M Irno; Fraboni, D; Panetta, P; Del Poeta, G; Lo Coco, F; Amadori, S; Arcese, W; Venditti, A
Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
2007 Del Poeta, G; Del Principe, M I; Luciano, F; Maurillo, L; Buccisano, F; Gattei, V; Niscola, P; Venditti, A; Imo Consalvo, M; Catalano, G; De Fabritiis, P; Amadori, S
Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia
2006 Buccisano, F; Maurillo, L; Gattei, V; Del Poeta, G; Del Principe, M I; Fraboni, D; Panetta, P; Consalvo, M Irno; Campagna, S; Gianni, L; Ottaviani, L; Postorino, M; De Fabritiis, P; Arcese, W; Lo Coco, F; Amadori, S; Venditti, A
The amount of c-kit receptor tyrosine: Kinase predicts outcome in acute myeloid leukemia (AML)
2001 Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Abruzzese, E; Tamburini, A; Suppo, G; Del Principe, Mi; Scornajenghi, Ka; Bruno, A; Cox, Mc; Masi, M; Amadori, S
Clinical Monoclonal B Cell Lymphocytosis Is a Strong Favorable Prognosticator Independent From Biological and Clinical Parameters
2011 Del Poeta, G; Del Principe, M I; Buccisano, F; Biagi, A; Bulian, P; Luciano, F; Zucchetto, A; Maurillo, L; Niscola, P; Perrotti, A P; Venditti, A; Gattei, V; De Fabritiis, P; Amadori, S
Functional characterization of AC133+peripheral blood stem cells
2001 Forte, L; Caravita, T; Santinelli, S; Siniscalchi, A; Di Cesare, S; Maurillo, L; Adorno, G; Ballatore, G; Bruno, A; Rossi, P; Amadori, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option | 2010 | Buccisano, F; Maurillo, L; Del Principe, M I; Cerretti, R; Consalvo M, A Irno; Fraboni, D; Panetta, P; Campagna, S; Ottaviani, L; Sarlo, C; De Angelis, G; Ditto, C; Di Caprio, L; Cefalo, M G; Ammatuna, E; Duranti, F; Lo Coco, F; Arcese, W; Amadori, S; Venditti, A | |
| Zoster-related pain in haematological malignancies: Prompt and stable relief of refractory pain syndromes by oxycodone | 2007 | Niscola, F; Cartoni, C; Piccioni, D; Del Poeta, G; Scaramucci, L; Romani, C; Maurillo, L; Palombi, M; Brunetti, G A; D'Elia, G M; Giovannini, M; Perrotti, A P; De Fabritiis, P | |
| Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL) | 2014 | Del Poeta, G; Del Principe, Mi; Dal Bo, M; Buccisano, F; Ragusa, D; Pozzo, F; Bulian, P; Maurillo, L; Rossi, D; Venditti, A; De Fabritiis, P; Gaidano, G; Amadori, S; Gattei, V | |
| Monitoring of minimal residual disease in acute myeloid leukemia using peripheral blood as an alternative source to bone marrow | 2007 | Maurillo, L; Buccisano, F; Del Poeta, G; Spagnoli, A; Neri, B; Del Principe, M I; Cupelli, L; Luciano, F; De Fabritiis, P; Amadori, S; Venditti, A | |
| Rituximab Maintenance Following Chemoimmunotherapy Improves Outcome in B-Cell Chronic Lymphocytic Leukemia | 2009 | Del Poeta, G; Del Principe, M I; Ragusa, D; Maurillo, L; Buccisano, F; Ottaviani, L; Gianni, L; Luciano, F; Bulian, P; Rossi, F M; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S | |
| The amount of spontaneous apoptosis predicts outcome in acute myeloid leukemia (AML) | 2000 | Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Del Moro, B; Suppo, G; Epiceno, Am; Cox, Mc; Masi, M; Amadori, S | |
| Umbilical cord blood banking: Variability in leukocyte count and differential by two automated hematology analysers | 1999 | Bruno, A; Ragusa, D; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Caravita, T; Zinno, F; Lanti, A; Santinelli, S; Buccisano, F; Tamburini, A; Maurillo, L; Picardi, A; Isacchi, G; Amadori, S | |
| Idiopathic hypereosinophilic syndrome (HES) with FIP1L1-PDGFRA rearrangement can be effectively treated with Imatinib | 2004 | Martinelli, G; Cilloni, D; Ottaviani, E; Malagola, M; Messa, F; Rondoni, M; Bosi, C; Gottardi, E; Rosti, G; Ricci, P; Gaitani, S; Pane, F; Testoni, N; Mecucci, C; Soverini, S; Piccaluga, Pp; Amabile, M; Tiribelli, M; Zaccaria, A; Grafone, T; De Vivo, A; Pileri, S; Fattori, P; Bocchia, M; Serra, A; Maurillo, L; Fanin, R; Cross, Ncp; Merante, S; Cazzola, M; Alimena, G; Frassoni, F; Galieni, P; Russo, D; Gobbi, M; Gugliotta, L; Lauria, F; Mazza, P; Ferrara, F; Gherlinzoni, F; Leoni, P; Musto, P; Baccarani, M; Saglio, G | |
| Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia | 2006 | Buccisano, F; Maurillo, L; Gattei, V; Del Poeta, G; Del Principe, M I; Fraboni, D; Panetta, P; Consalvo, M Irno; Campagna, S; Gianni, L; Ottaviani, L; Postorino, M; De Fabritiis, P; Arcese, W; Lo Coco, F; Amadori, S; Venditti, A | |
| Bcl-2 overexpression identifies a subset of patients with acute myeloid leukemia at worse prognosis within the intermediate/favorable cytogenetic risk group | 1998 | Del Poeta, G; Venditti, A; Aronica, G; Buccisano, F; Cox, Mc; Maurillo, L; Tamburini, A; Bruno, A; Masi, M; Amadori, S | |
| Hodgkin lymphoma in mutated ZAP-70 negative B-CELL chronic lymphocytic leukemia: A case report | 2007 | Niscola, P; Del Principe, M I; Palombi, M; Fratoni, S; Piccioni, D; Maurillo, L; De Fabritiis, P; Amadori, S; Del Poeta, G | |
| Minimal residual disease is detectable in peripheral blood of patients with acute myeloid leukemia and provides prognostic information | 2007 | Maurillo, L; Buccisano, F; Del Poeta, G; Spagnoli, A; Neri, B; Del Principe, M I; Ammatuna, E; Tendas, A; Luciano, F; De Fabritiis, P; Amadori, S; Vendetti, A | |
| P-glycoprotein (PGP) and CD71 overexpression combined with low bcl-2 identify patients at worse prognosis in acute lymphoid leukemia (ALL) | 1999 | Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Cox, Mc; Epiceno, Am; Del Moro, B; Battaglia, A; Del Principe, Mi; Bruno, A; Masi, M; Amadori, S | |
| Clinical relevance of bcl-2 expression in de novo acute myeloid leukemia (AML) | 1999 | Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Tamburini, A; Cox, Mc; Epiceno, Am; Del Moro, B; Battaglia, A; Del Principe, Mid; Bruno, A; Masi, M; Amadori, S | |
| Risk-adapted transplant selection improves outcome of adult patients with high-risk AML | 2012 | Buccisano, F; Maurillo, L; Del Principe, M I; Cerretti, R; Sarlo, C; Picardi, A; Cefalo, M; Ottaviani, L; De Angelis, G; Ditto, C; Di Veroli, A; Consalvo, M Irno; Fraboni, D; Panetta, P; Del Poeta, G; Lo Coco, F; Amadori, S; Arcese, W; Venditti, A | |
| Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL) | 2007 | Del Poeta, G; Del Principe, M I; Luciano, F; Maurillo, L; Buccisano, F; Gattei, V; Niscola, P; Venditti, A; Imo Consalvo, M; Catalano, G; De Fabritiis, P; Amadori, S | |
| Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia | 2006 | Buccisano, F; Maurillo, L; Gattei, V; Del Poeta, G; Del Principe, M I; Fraboni, D; Panetta, P; Consalvo, M Irno; Campagna, S; Gianni, L; Ottaviani, L; Postorino, M; De Fabritiis, P; Arcese, W; Lo Coco, F; Amadori, S; Venditti, A | |
| The amount of c-kit receptor tyrosine: Kinase predicts outcome in acute myeloid leukemia (AML) | 2001 | Del Poeta, G; Venditti, A; Maurillo, L; Buccisano, F; Abruzzese, E; Tamburini, A; Suppo, G; Del Principe, Mi; Scornajenghi, Ka; Bruno, A; Cox, Mc; Masi, M; Amadori, S | |
| Clinical Monoclonal B Cell Lymphocytosis Is a Strong Favorable Prognosticator Independent From Biological and Clinical Parameters | 2011 | Del Poeta, G; Del Principe, M I; Buccisano, F; Biagi, A; Bulian, P; Luciano, F; Zucchetto, A; Maurillo, L; Niscola, P; Perrotti, A P; Venditti, A; Gattei, V; De Fabritiis, P; Amadori, S | |
| Functional characterization of AC133+peripheral blood stem cells | 2001 | Forte, L; Caravita, T; Santinelli, S; Siniscalchi, A; Di Cesare, S; Maurillo, L; Adorno, G; Ballatore, G; Bruno, A; Rossi, P; Amadori, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 01 Pubblicazione su rivista2116
Data di pubblicazione
- 2020 - 2026687
- 2010 - 2019862
- 2000 - 2009452
- 1990 - 1999111
- 1980 - 19892
- 1974 - 19792
Editore
- AMER SOC HEMATOLOGY71
- ELSEVIER17
- SPRINGER17
- ELSEVIER SCIENCE INC14
- WILEY14
- ASSOC RESEARCH VISION OPHTHALMOLOGY INC12
- Minerva medica12
- AMER DIABETES ASSOC11
- CIG MEDIA GROUP, LP10
- LIPPINCOTT WILLIAMS & WILKINS10
Prodotti per rivista
- BLOOD167
- CIRCULATION56
- EUROPEAN HEART JOURNAL54
- ULTRASOUND IN OBSTETRICS & GYNECOLOGY54
- HAEMATOLOGICA53
- ANNALS OF ONCOLOGY51
- ARCHIVIO STORICO ITALIANO35
- MEDITERRANEAN JOURNAL OF CLINICAL PSYCHOLOGY35
- JOURNAL OF CLINICAL ONCOLOGY34
- JOURNAL OF SLEEP RESEARCH27
Prodotti per parola chiave
- sleep19
- melanoma16
- CML10
- Hypertention10
- EEG9
- Hypertension9
- Alexithymia8
- Ipertensione8
- asciminib6
- cancer6
Lingua
- eng1683
- ita198
- fre4
- spa3
- alb1
Accesso al fulltext
- no fulltext2036
- open45
- reserved32
- partially open3